LymphedemaV1, Main, Exploration, bibRecord, 002640

Proactive Approach to Lymphedema Risk Reduction: A Prospective Study

Identifieur interne : 002640 ( Main/Exploration ); précédent : 002639; suivant : 002641

Proactive Approach to Lymphedema Risk Reduction: A Prospective Study

Auteurs : Mei R. Fu [États-Unis] ; Deborah Axelrod [États-Unis] ; Amber A. Guth [États-Unis] ; Francis Cartwright [États-Unis] ; Zeyuan Qiu [États-Unis] ; Judith D. Goldberg ; June Kim ; Joan Scagliola [États-Unis] ; Robin Kleinman [États-Unis] ; Judith Haber [États-Unis]

Source :

Annals of surgical oncology [ 1068-9265 ] ; 2014.

RBID : PMC:4163073

Descripteurs français

KwdFr :
- Adulte, Adulte d'âge moyen, Autosoins, Biopsie de noeud lymphatique sentinelle (effets indésirables), Complications postopératoires (), Complications postopératoires (étiologie), Comportement de réduction des risques, Enquêtes et questionnaires, Femelle, Humains, Lymphadénectomie (effets indésirables), Lymphoedème (), Lymphoedème (étiologie), Projets pilotes, Pronostic, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Études de suivi, Études longitudinales, Études prospectives.
MESH :
- anatomopathologie : Tumeurs du sein.
- effets indésirables : Biopsie de noeud lymphatique sentinelle, Lymphadénectomie.
- étiologie : Complications postopératoires, Lymphoedème.
- Adulte, Adulte d'âge moyen, Autosoins, Complications postopératoires, Comportement de réduction des risques, Enquêtes et questionnaires, Femelle, Humains, Lymphoedème, Projets pilotes, Pronostic, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs du sein, Études de suivi, Études longitudinales, Études prospectives.

English descriptors

KwdEn :
- Adult, Aged, Aged, 80 and over, Breast Neoplasms (pathology), Breast Neoplasms (surgery), Female, Follow-Up Studies, Humans, Longitudinal Studies, Lymph Node Excision (adverse effects), Lymphedema (etiology), Lymphedema (prevention & control), Middle Aged, Neoplasm Staging, Pilot Projects, Postoperative Complications (etiology), Postoperative Complications (prevention & control), Prognosis, Prospective Studies, Risk Reduction Behavior, Self Care, Sentinel Lymph Node Biopsy (adverse effects), Surveys and Questionnaires.
MESH :
- adverse effects : Lymph Node Excision, Sentinel Lymph Node Biopsy.
- etiology : Lymphedema, Postoperative Complications.
- pathology : Breast Neoplasms.
- prevention & control : Lymphedema, Postoperative Complications.
- surgery : Breast Neoplasms.
- Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Humans, Longitudinal Studies, Middle Aged, Neoplasm Staging, Pilot Projects, Prognosis, Prospective Studies, Risk Reduction Behavior, Self Care, Surveys and Questionnaires.

Abstract

Background

Advances in cancer treatments continue to reduce the incidence of lymphedema. Yet, many breast cancer survivors still face long-term post-operative challenges as a result of developing lymphedema. The purpose of this study was to preliminarily evaluate The-Optimal-Lymph-Flow program, a patient-centered education and behavioral program focusing on self-care strategies to enhance lymphedema risk reduction by promoting lymph flow and optimize body mass index.

Methods

A prospective, longitudinal, quasi-experimental design with repeated-measures was used. The study outcomes included lymph volume changes by infra-red perometer and body mass index by a bioimpedance device at pre-surgery baseline, 2-4 weeks after surgery, 6-month, and 12-month follow-up. A total of 140 patients were recruited and participated in The-Optimal-Lymph-Flow program; 134 patients completed the study with 4% attrition rate.

Results

Fifty-eight percent patients had axillary node dissection and 42% had sentinel lymph node biopsy. The majority (97%) of patients maintained and improved their preoperative limb volume and body mass index at the study endpoint of 12 months following cancer surgery. Cumulatively, 2 patients with sentinel lymph node biopsy and 2 patients with the axillary lymph node dissection had measurable lymphedema (>10% limb volume change). At 12-month follow-up, among the 4 patients with measurable lymphedema, 2 patients' limb volume returned to pre-operative level without compression therapy but by maintaining The-Optimal-Lymph-Flow exercises to promote daily lymph flow.

Conclusions

This educational and behavioral program is effective to enhance lymphedema risk reduction. The study provided initial evidence for emerging change in lymphedema care from treatment-focus to proactive risk reduction.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163073

DOI: 10.1245/s10434-014-3761-z
PubMed: 24809302
PubMed Central: 4163073

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Proactive Approach to Lymphedema Risk Reduction: A Prospective Study</title>
<author><name sortKey="Fu, Mei R" sort="Fu, Mei R" uniqKey="Fu M" first="Mei R." last="Fu">Mei R. Fu</name>
<affiliation wicri:level="2"><nlm:aff id="A1">College of Nursing, New York University, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>College of Nursing, New York University, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Axelrod, Deborah" sort="Axelrod, Deborah" uniqKey="Axelrod D" first="Deborah" last="Axelrod">Deborah Axelrod</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Surgery, New York University School of Medicine, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A3">NYU Clinical Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>NYU Clinical Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guth, Amber A" sort="Guth, Amber A" uniqKey="Guth A" first="Amber A." last="Guth">Amber A. Guth</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Surgery, New York University School of Medicine, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A3">NYU Clinical Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>NYU Clinical Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Cartwright, Francis" sort="Cartwright, Francis" uniqKey="Cartwright F" first="Francis" last="Cartwright">Francis Cartwright</name>
<affiliation wicri:level="2"><nlm:aff id="A3">NYU Clinical Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>NYU Clinical Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Qiu, Zeyuan" sort="Qiu, Zeyuan" uniqKey="Qiu Z" first="Zeyuan" last="Qiu">Zeyuan Qiu</name>
<affiliation wicri:level="2"><nlm:aff id="A4">New Jersey Institute of Technology, Newark, NJ</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>New Jersey Institute of Technology, Newark</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Goldberg, Judith D" sort="Goldberg, Judith D" uniqKey="Goldberg J" first="Judith D." last="Goldberg">Judith D. Goldberg</name>
<affiliation><nlm:aff id="A5">Division of Biostatistics, New York University School of Medicine</nlm:aff>
<wicri:noCountry code="subfield">New York University School of Medicine</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Kim, June" sort="Kim, June" uniqKey="Kim J" first="June" last="Kim">June Kim</name>
<affiliation><nlm:aff id="A5">Division of Biostatistics, New York University School of Medicine</nlm:aff>
<wicri:noCountry code="subfield">New York University School of Medicine</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Scagliola, Joan" sort="Scagliola, Joan" uniqKey="Scagliola J" first="Joan" last="Scagliola">Joan Scagliola</name>
<affiliation wicri:level="2"><nlm:aff id="A3">NYU Clinical Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>NYU Clinical Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kleinman, Robin" sort="Kleinman, Robin" uniqKey="Kleinman R" first="Robin" last="Kleinman">Robin Kleinman</name>
<affiliation wicri:level="2"><nlm:aff id="A3">NYU Clinical Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>NYU Clinical Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Haber, Judith" sort="Haber, Judith" uniqKey="Haber J" first="Judith" last="Haber">Judith Haber</name>
<affiliation wicri:level="2"><nlm:aff id="A1">College of Nursing, New York University, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>College of Nursing, New York University, New York</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">24809302</idno>
<idno type="pmc">4163073</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163073</idno>
<idno type="RBID">PMC:4163073</idno>
<idno type="doi">10.1245/s10434-014-3761-z</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">003981</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003981</idno>
<idno type="wicri:Area/Pmc/Curation">003980</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003980</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001858</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001858</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">001528</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001528</idno>
<idno type="wicri:Area/PubMed/Curation">001528</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001528</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001528</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001528</idno>
<idno type="wicri:Area/Ncbi/Merge">006646</idno>
<idno type="wicri:Area/Ncbi/Curation">006646</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">006646</idno>
<idno type="wicri:doubleKey">1068-9265:2014:Fu M:proactive:approach:to</idno>
<idno type="wicri:Area/Main/Merge">002644</idno>
<idno type="wicri:Area/Main/Curation">002640</idno>
<idno type="wicri:Area/Main/Exploration">002640</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Proactive Approach to Lymphedema Risk Reduction: A Prospective Study</title>
<author><name sortKey="Fu, Mei R" sort="Fu, Mei R" uniqKey="Fu M" first="Mei R." last="Fu">Mei R. Fu</name>
<affiliation wicri:level="2"><nlm:aff id="A1">College of Nursing, New York University, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>College of Nursing, New York University, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Axelrod, Deborah" sort="Axelrod, Deborah" uniqKey="Axelrod D" first="Deborah" last="Axelrod">Deborah Axelrod</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Surgery, New York University School of Medicine, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A3">NYU Clinical Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>NYU Clinical Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guth, Amber A" sort="Guth, Amber A" uniqKey="Guth A" first="Amber A." last="Guth">Amber A. Guth</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Surgery, New York University School of Medicine, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A3">NYU Clinical Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>NYU Clinical Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Cartwright, Francis" sort="Cartwright, Francis" uniqKey="Cartwright F" first="Francis" last="Cartwright">Francis Cartwright</name>
<affiliation wicri:level="2"><nlm:aff id="A3">NYU Clinical Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>NYU Clinical Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Qiu, Zeyuan" sort="Qiu, Zeyuan" uniqKey="Qiu Z" first="Zeyuan" last="Qiu">Zeyuan Qiu</name>
<affiliation wicri:level="2"><nlm:aff id="A4">New Jersey Institute of Technology, Newark, NJ</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>New Jersey Institute of Technology, Newark</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Goldberg, Judith D" sort="Goldberg, Judith D" uniqKey="Goldberg J" first="Judith D." last="Goldberg">Judith D. Goldberg</name>
<affiliation><nlm:aff id="A5">Division of Biostatistics, New York University School of Medicine</nlm:aff>
<wicri:noCountry code="subfield">New York University School of Medicine</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Kim, June" sort="Kim, June" uniqKey="Kim J" first="June" last="Kim">June Kim</name>
<affiliation><nlm:aff id="A5">Division of Biostatistics, New York University School of Medicine</nlm:aff>
<wicri:noCountry code="subfield">New York University School of Medicine</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Scagliola, Joan" sort="Scagliola, Joan" uniqKey="Scagliola J" first="Joan" last="Scagliola">Joan Scagliola</name>
<affiliation wicri:level="2"><nlm:aff id="A3">NYU Clinical Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>NYU Clinical Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kleinman, Robin" sort="Kleinman, Robin" uniqKey="Kleinman R" first="Robin" last="Kleinman">Robin Kleinman</name>
<affiliation wicri:level="2"><nlm:aff id="A3">NYU Clinical Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>NYU Clinical Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Haber, Judith" sort="Haber, Judith" uniqKey="Haber J" first="Judith" last="Haber">Judith Haber</name>
<affiliation wicri:level="2"><nlm:aff id="A1">College of Nursing, New York University, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>College of Nursing, New York University, New York</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of surgical oncology</title>
<idno type="ISSN">1068-9265</idno>
<idno type="eISSN">1534-4681</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (prevention & control)</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Pilot Projects</term>
<term>Postoperative Complications (etiology)</term>
<term>Postoperative Complications (prevention & control)</term>
<term>Prognosis</term>
<term>Prospective Studies</term>
<term>Risk Reduction Behavior</term>
<term>Self Care</term>
<term>Sentinel Lymph Node Biopsy (adverse effects)</term>
<term>Surveys and Questionnaires</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Autosoins</term>
<term>Biopsie de noeud lymphatique sentinelle (effets indésirables)</term>
<term>Complications postopératoires ()</term>
<term>Complications postopératoires (étiologie)</term>
<term>Comportement de réduction des risques</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (étiologie)</term>
<term>Projets pilotes</term>
<term>Pronostic</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Études de suivi</term>
<term>Études longitudinales</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term>
<term>Sentinel Lymph Node Biopsy</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term>
<term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Pilot Projects</term>
<term>Prognosis</term>
<term>Prospective Studies</term>
<term>Risk Reduction Behavior</term>
<term>Self Care</term>
<term>Surveys and Questionnaires</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Autosoins</term>
<term>Complications postopératoires</term>
<term>Comportement de réduction des risques</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Projets pilotes</term>
<term>Pronostic</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
<term>Études longitudinales</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title>
<p id="P1">Advances in cancer treatments continue to reduce the incidence of lymphedema. Yet, many breast cancer survivors still face long-term post-operative challenges as a result of developing lymphedema. The purpose of this study was to preliminarily evaluate <italic>The-Optimal-Lymph-Flow</italic>
 program, a patient-centered education and behavioral program focusing on self-care strategies to enhance lymphedema risk reduction by promoting lymph flow and optimize body mass index.</p>
</sec>
<sec id="S2"><title>Methods</title>
<p id="P2">A prospective, longitudinal, quasi-experimental design with repeated-measures was used. The study outcomes included lymph volume changes by <italic>infra-red perometer</italic>
 and body mass index by a <italic>bioimpedance</italic>
 device at pre-surgery baseline, 2-4 weeks after surgery, 6-month, and 12-month follow-up. A total of 140 patients were recruited and participated in <italic>The-Optimal-Lymph-Flow</italic>
 program; 134 patients completed the study with 4% attrition rate.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">Fifty-eight percent patients had axillary node dissection and 42% had sentinel lymph node biopsy. The majority (97%) of patients maintained and improved their preoperative limb volume and body mass index at the study endpoint of 12 months following cancer surgery. Cumulatively, 2 patients with sentinel lymph node biopsy and 2 patients with the axillary lymph node dissection had measurable lymphedema (>10% limb volume change). At 12-month follow-up, among the 4 patients with measurable lymphedema, 2 patients' limb volume returned to pre-operative level without compression therapy but by maintaining <italic>The-Optimal-Lymph-Flow</italic>
 exercises to promote daily lymph flow.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">This educational and behavioral program is effective to enhance lymphedema risk reduction. The study provided initial evidence for emerging change in lymphedema care from treatment-focus to proactive risk reduction.</p>
</sec>
</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>New Jersey</li>
<li>État de New York</li>
</region>
</list>
<tree><noCountry><name sortKey="Goldberg, Judith D" sort="Goldberg, Judith D" uniqKey="Goldberg J" first="Judith D." last="Goldberg">Judith D. Goldberg</name>
<name sortKey="Kim, June" sort="Kim, June" uniqKey="Kim J" first="June" last="Kim">June Kim</name>
</noCountry>
<country name="États-Unis"><region name="État de New York"><name sortKey="Fu, Mei R" sort="Fu, Mei R" uniqKey="Fu M" first="Mei R." last="Fu">Mei R. Fu</name>
</region>
<name sortKey="Axelrod, Deborah" sort="Axelrod, Deborah" uniqKey="Axelrod D" first="Deborah" last="Axelrod">Deborah Axelrod</name>
<name sortKey="Axelrod, Deborah" sort="Axelrod, Deborah" uniqKey="Axelrod D" first="Deborah" last="Axelrod">Deborah Axelrod</name>
<name sortKey="Cartwright, Francis" sort="Cartwright, Francis" uniqKey="Cartwright F" first="Francis" last="Cartwright">Francis Cartwright</name>
<name sortKey="Guth, Amber A" sort="Guth, Amber A" uniqKey="Guth A" first="Amber A." last="Guth">Amber A. Guth</name>
<name sortKey="Guth, Amber A" sort="Guth, Amber A" uniqKey="Guth A" first="Amber A." last="Guth">Amber A. Guth</name>
<name sortKey="Haber, Judith" sort="Haber, Judith" uniqKey="Haber J" first="Judith" last="Haber">Judith Haber</name>
<name sortKey="Kleinman, Robin" sort="Kleinman, Robin" uniqKey="Kleinman R" first="Robin" last="Kleinman">Robin Kleinman</name>
<name sortKey="Qiu, Zeyuan" sort="Qiu, Zeyuan" uniqKey="Qiu Z" first="Zeyuan" last="Qiu">Zeyuan Qiu</name>
<name sortKey="Scagliola, Joan" sort="Scagliola, Joan" uniqKey="Scagliola J" first="Joan" last="Scagliola">Joan Scagliola</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002640 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002640 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:4163073
   |texte=   Proactive Approach to Lymphedema Risk Reduction: A Prospective Study
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24809302" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Proactive Approach to Lymphedema Risk Reduction: A Prospective Study

Proactive Approach to Lymphedema Risk Reduction: A Prospective Study

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.